Birdwatch Note Rating
2023-09-05 21:23:42 UTC - HELPFUL
Rated by Participant: C8EBF0728DEDBC8ABEE760F07C0F6C9D05C3FA2B5E42F911E9EDACACFAC7EE72
Participant Details
Original Note:
Pfizer data submitted for booster approval was on more than 23 people. "Safety was evaluated in 306 participants 18 through 55 years of age and 12 participants 65 years of age and older who were followed for an average of over two months." per FDA approval announcement https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations
All Note Details